510(k) K150850
K150850 is an FDA 510(k) premarket notification submitted by Biomet, Inc. for the device "Refobacin Bone Cement R". The FDA issued a decision of Substantially Equivalent on July 16, 2015. The device falls under product code MBB (Bone Cement, Antibiotic), a Class II device regulated under 21 CFR 888.3027. Biomet, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 16, 2015
- Date Received
- March 31, 2015
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Bone Cement, Antibiotic
- Device Class
- Class II
- Regulation Number
- 888.3027
- Review Panel
- OR
- Submission Type